U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Tailor Cut Produce Inc. - 605078 - 03/04/2021
  1. Warning Letters


Tailor Cut Produce Inc. MARCS-CMS 605078 —

Delivery Method:
VIA UPS and Electronic Mail
Food & Beverages

Recipient Name
Dawn C. Young
Recipient Title
Tailor Cut Produce Inc.

832 Ridgewood Avenue
North Brunswick, NJ 08902
United States

Issuing Office:
Division of Human and Animal Food Operations East II

United States

Dear Ms. Young,

The Food & Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter 605078, dated July 8, 2020. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations, or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Jessica D. Weber
Compliance Officer
Baltimore District Office
Human & Animal Food East, Division 2
Office of Regulatory Affairs
U.S. Food and Drug Administration

Cc (via email):
Randy F. Pack, Program Division Director, District Director (randy.pack@fda.hhs.gov)
JoAnn DeClement, State Liaison (joann.declement@fda.hhs.gov)
Laishan Liza Lam, Acting Director, Compliance Branch (laishan.lam@fda.hhs.gov)
Martin J. Guardia, Director, Investigations Branch (martin.guardia@fda.hhs.gov)
Raymond Cheung, Supervisory Consumer Safety Officer (raymond.cheung@fda.hhs.gov)

Back to Top